Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children
NCT00456469 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2007-04-05
Summary
Study based in Southern Ethiopia Purpose - to explore if children in contact with adults with TB have positive acute reactants such as IFN-y and other cytokine responses; if these responses discriminate between high and low risk of disease progression and whether these could be incorporated into improved diagnostic approaches.
Conditions
Sponsors & Collaborators
-
Thrasher Research Fund
collaborator OTHER -
Liverpool School of Tropical Medicine
lead OTHER
Principal Investigators
-
Luis Cuevas, Dr · Liverpool School of Tropical Medicine
Eligibility
- Min Age
- 1 Year
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-05-31
- Completion
- 2009-10-31
Countries
- Ethiopia
Study Locations
More Related Trials
-
Determining Risk in Latent Tuberculosis
NCT01571739 ·Status: TERMINATED
-
Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden
NCT05190146 ·Status: COMPLETED
-
Tuberculosis Infection in Women of Reproductive Age and Their Infants
NCT03305991 ·Status: COMPLETED
-
A Phase II Study of H56:IC31 in Healthy Adolescents
NCT03265977 ·Status: WITHDRAWN ·Phase: PHASE2
-
Prevalence of Latent Tuberculosis in High Risk Children
NCT03910946 ·Status: UNKNOWN
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
A Multicentre, Cohort Study of Screening and Preventive Intervention for Latent Tuberculosis Infection in Children
NCT04156568 ·Status: UNKNOWN ·Phase: PHASE1
-
Host Blood RNA Signatures for Diagnosis of TB
NCT05542511 ·Status: ACTIVE_NOT_RECRUITING
-
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence
NCT03512249 ·Status: COMPLETED ·Phase: PHASE2
-
Integrating Pediatric TB Services Into Child Healthcare Services in Africa
NCT03862261 ·Status: COMPLETED ·Phase: NA
-
Evaluation of an Innovative Tuberculosis Diagnostic Test
NCT02573623 ·Status: UNKNOWN
-
Tuberculosis Prevention for HIV Infected Adults
NCT00057122 ·Status: COMPLETED ·Phase: PHASE3
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB
NCT01099098 ·Status: COMPLETED
-
The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis
NCT00982969 ·Status: COMPLETED
-
Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection
NCT02512939 ·Status: COMPLETED ·Phase: NA
-
The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis
NCT06580639 ·Status: RECRUITING
-
Immune Response to Mycobacterium Tuberculosis Infection
NCT00257907 ·Status: COMPLETED
-
Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)
NCT01331811 ·Status: COMPLETED ·Phase: NA
-
Improving Latent Tuberculosis (TB) Diagnosis in Thai Children
NCT00947609 ·Status: COMPLETED
-
Integrated Discovery and Development of Innovative TB Diagnostics
NCT06624501 ·Status: COMPLETED
-
Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis
NCT04995406 ·Status: COMPLETED
-
Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers
NCT00311220 ·Status: UNKNOWN ·Phase: PHASE4
-
The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa
NCT01990274 ·Status: COMPLETED ·Phase: NA
-
Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness
NCT00931736 ·Status: COMPLETED ·Phase: PHASE3